1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Epiomic Epidemiology Series: Stomach Cancer Forecast in 17 Major Markets 2016-2026

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Stomach Cancer in 17 Major Markets

Stomach cancer is a broad term encompassing tumours arising in the stomach and includes gastric carcinoma which is a malignant epithelial-origin tumour commonly developing after prolonged periods of gastritis. Stomach cancers tend to develop slowly over many years spreading in different ways. Long-term infection of the stomach with Helicobacter pylori may lead to inflammation (known as chronic atrophic gastritis) and pre-cancerous changes to the inner lining of the stomach.

This report provides the current incident population for Stomach Cancer across 17 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Mexico, Turkey, Argentina, Australia, Canada, Russian, Saudi Arabia and South Africa) split by gender and 5-year age cohort. Along with the current incidence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the classifications and co-morbidities of Stomach Cancer have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main features and co-morbidities associated with Stomach Cancer include:

-History of stomach polyps or stomach lymphoma
-Family history of stomach cancer
-Colorectal cancer
-Familial adenomatous polyposis
-BRCA1/BRCA2 mutations
-Megaloblastic (pernicious) anaemia or being blood type A

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

-Able to quantify patient populations in global Stomach Cancer’s market to target the development of future products, pricing strategies and launch plans.
-Gain further insight into the incidence of the subdivided types of Stomach Cancer and identify patient segments with high potential.
-Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
-Provide a level of understanding on the impact from specific co-morbid conditions on Stomach Cancer’s incident population.
-Identify sub-populations within Stomach Cancer which require treatment.
-Gain an understanding of the specific markets that have the largest number of Stomach Cancer patients.

Table Of Contents

Epiomic Epidemiology Series: Stomach Cancer Forecast in 17 Major Markets 2016-2026
Table of Contents
-List of Tables and Figures
-Introduction
-Cause of the Disease
-Risk Factors and Prevention
-Diagnosis of the Disease
-Variation by Geography/Ethnicity
-Disease Prognosis and Clinical Course
-Key Co-morbid Conditions/ Features Associated with the Disease
-Methodology for Quantification of Patient Numbers
o Additional data available on request
-Top-Line Incidence for Stomach Cancer
-Stages and Grading of Stomach Cancer
o Location of Tumour
o Histopathology of Tumour Cells in Stomach Cancer
o Lauren Classification of Stomach Cancer
o Co-morbidity of H. Pylori infection in Stomach Cancer
-Abbreviations used in the Report
-Other Black Swan Analysis Publications
-Black Swan Analysis Online Patient-Based Databases
-Patient-Based Offering
-Online Pricing Data and Platforms
-References
-Appendix


List of Tables
-AJCC Tumour Grading Classification for Stomach Cancer
-Incidence of Stomach Cancer, total (000s)
-Incidence of Stomach Cancer, males (000s)
-Incidence of Stomach Cancer, females (000s)
-AJCC Stage at diagnosis for Stomach cancer patients, total (000s)
-Location of tumour cells in Stomach Cancer patients, total (000s)
-Major histopathological type of Stomach Cancer, total (000s)
-Lauren Classification of Adenocarcinoma subtypes in SC patients, total (000s)
-H. Pylori infection in Stomach cancer, total (000s)
-Abbreviations and Acronyms used in the report
-USA Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
-USA Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
-France Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
-France Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
-Germany Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
-Germany Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
-Italy Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
-Italy Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
-Spain Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
-Spain Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
-United Kingdom Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
-United Kingdom Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
-Brazil Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
-Brazil Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
-Japan Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
-Japan Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
-India Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
-India Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
-Mexico Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
-Mexico Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
-Turkey Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
-Turkey Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
-Argentina Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
-Argentina Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
-Australia Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
-Australia Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
-Canada Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
-Canada Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
-Russia Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
-Russia Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
-Saudi Arabia Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
-Saudi Arabia Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
-South Africa Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
-South Africa Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
?

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016-2021 Future Horizons and Growth Strategies in the UK Hospital Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

2016-2021 Future Horizons and Growth Strategies in the UK Hospital Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 2500
  • Industry report
  • November 2016
  • by Venture Planning Group

This new report from VPGMarketResearch contains 527 pages, 37 tables, and presents a comprehensive analysis of the UK hospital tumor marker testing market, including:  Major issues pertaining to the UK ...

2016-2021 Future Horizons and Growth Strategies in the German Hospital Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

2016-2021 Future Horizons and Growth Strategies in the German Hospital Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 2500
  • Industry report
  • November 2016
  • by Venture Planning Group

This new report from VPGMarketResearch contains 530 pages, 40 tables, and presents a comprehensive analysis of the German hospital tumor marker testing market, including:   Major issues pertaining to ...

2016-2021 Future Horizons and Growth Strategies in the Japanese Hospital Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

2016-2021 Future Horizons and Growth Strategies in the Japanese Hospital Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 3500
  • Industry report
  • November 2016
  • by Venture Planning Group

This new report from VPGMarketResearch contains 537 pages, 42 tables, and presents a comprehensive analysis of the Japanese hospital tumor marker testing market, including:  Major issues pertaining to ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the US

  • December 2016
    112 pages
  • Cancer  

  • United States  

    North America  

View report >

Cancer Statistics in the UK

  • October 2016
    24 pages
  • Cancer  

  • United Kingdom  

    Europe  

View report >

Cancer Statistics in the UK

  • October 2016
    2 pages
  • Cancer  

  • United Kingdom  

    Europe  

View report >

Related Market Segments :

Stomach Cancer

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.